Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window
NCT07476898
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
864
Enrollment
OTHER
Sponsor class
Conditions
Stroke
Interventions
DRUG:
Tenecteplase (0.25mg/kg)
DRUG:
Standard Medical Management
Sponsor
First Hospital of China Medical University